TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Net interest income | ---- | -13.37%8.08B | 5.88%7.57B | -22.16%17.65B | ---- | -17.83%9.33B | 16.24%7.15B | -9.97%22.67B | ---- | -16.19%11.35B |
-Interest income | ---- | -7.86%28.16B | ---- | -2.09%60.32B | ---- | 1.49%30.56B | ---- | -1.46%61.6B | ---- | -4.67%30.11B |
-Interest expense | ---- | 5.44%-20.08B | ---- | -9.60%-42.67B | ---- | -13.18%-21.23B | ---- | -4.27%-38.93B | ---- | -3.97%-18.76B |
Net service income | ---- | -3.92%1.7B | ---- | 55.65%4B | ---- | 23.72%1.77B | ---- | 14.81%2.57B | ---- | 27.69%1.43B |
-Service income | ---- | -2.22%2.25B | ---- | 43.42%5.08B | ---- | 22.06%2.31B | ---- | -9.03%3.54B | ---- | -14.32%1.89B |
-Service charge | ---- | -3.35%-558.6M | ---- | -11.07%-1.08B | ---- | -16.95%-540.51M | ---- | 41.28%-971.26M | ---- | 57.49%-462.17M |
Net transaction income | ---- | -22.51%388.43M | ---- | 323.58%502.03M | ---- | 256.30%501.27M | ---- | ---224.54M | ---- | ---320.72M |
Securities and investments income | ---- | 103.96%2.96B | ---- | 99.29%2.76B | ---- | 46.33%1.45B | ---- | -0.88%1.39B | ---- | -16.27%993.05M |
Special items of operating revenue | ---- | -53.06%16.53M | ---- | 33.22%87.14M | ---- | -12.16%35.22M | ---- | -82.71%65.41M | ---- | 190.21%40.09M |
Operating revenue | 2.64%19.85B | 0.48%13.14B | -5.55%25B | -4.11%19.34B | -3.03%13.08B | -9.35%26.47B | -11.40%20.17B | -14.63%13.49B | ||
Operating expenses - before deducting impairment | ---- | 6.38%-5.02B | ---- | 1.72%-10.71B | ---- | -11.39%-5.36B | ---- | -6.74%-10.9B | ---- | -2.13%-4.81B |
Operating profit before deducting impairment | 5.24%8.13B | -8.22%14.28B | -11.02%7.72B | -18.00%15.56B | -21.75%8.68B | |||||
Impairment and provisions | ---- | -30.96%-4.01B | ---- | -0.75%-9.12B | ---- | 16.11%-3.06B | ---- | -4.32%-9.05B | ---- | 16.44%-3.65B |
-Impairment losses of other assets | ---- | -30.96%-4.01B | ---- | -0.75%-9.12B | ---- | 16.11%-3.06B | ---- | -4.32%-9.05B | ---- | 16.44%-3.65B |
Operating profit after deducting impairment | -11.68%4.11B | -20.71%5.16B | -7.33%4.66B | -36.81%6.51B | -25.20%5.03B | |||||
Operating profit | -11.68%4.11B | -20.71%5.16B | -7.33%4.66B | -36.81%6.51B | -25.20%5.03B | |||||
Earning before tax | -11.68%4.11B | -20.71%5.16B | -7.33%4.66B | -36.81%6.51B | -25.20%5.03B | |||||
Tax | ---- | 25.46%-417.25M | ---- | 79.66%-82.17M | ---- | 10.28%-559.75M | ---- | 75.87%-403.98M | ---- | 54.66%-623.92M |
After-tax profit from continuing operations | -9.80%3.7B | -16.81%5.08B | -6.91%4.1B | -29.23%6.11B | -17.62%4.4B | |||||
Earning After tax | -4.61%4.77B | -9.80%3.7B | -17.76%3.05B | -16.81%5.08B | -7.38%5B | -6.91%4.1B | 2.25%3.71B | -29.23%6.11B | -10.92%5.39B | -17.62%4.4B |
Profits attributable to shareholders | -9.80%3.7B | -16.81%5.08B | -6.91%4.1B | -29.23%6.11B | -17.62%4.4B | |||||
Basic earnings per share | -8.70%0.21 | -20.69%0.23 | -8.00%0.23 | -32.56%0.29 | -16.67%0.25 | |||||
Diluted earnings per share | -8.70%0.21 | -20.69%0.23 | -8.00%0.23 | -32.56%0.29 | -16.67%0.25 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.